v3.26.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Product revenues, net $ 13,942 $ 56,839
Cost of goods sold 4,334 11,877
Gross Profit 9,608 44,962
Expenses:        
Research and development 3,892,387 816,697 4,903,789 2,042,890
General and administrative 1,912,927 1,480,356 5,642,824 4,057,046
Total operating expenses 5,805,314 2,297,053 10,546,613 6,099,936
Operating loss (5,795,706) (2,297,053) (10,501,651) (6,099,936)
Other Income (Expenses):        
Interest income 7,223 10,212 35,695 33,627
Loss on change in fair value of convertible notes (1,252,798) (702,418)
Loss on change in fair value of license consideration payable (114,691) (114,691)
Interest expense (68,098) (1,193) (277,360) (3,557)
Total other income (expenses), net (1,428,364) 9,019 (1,058,774) 30,070
Net loss $ (7,224,070) $ (2,288,034) $ (11,560,425) $ (6,069,866)
Net loss per common share:        
Basic $ (7.42) $ (5.04) $ (17.28) $ (13.61)
Diluted $ (7.42) $ (5.04) $ (17.28) $ (13.61)
Weighted average number of common shares outstanding:        
Basic 973,633 453,865 668,936 445,933
Diluted 973,633 453,865 668,936 445,933